Power Hour Surge: Cover Story, FDA Catalysts, Rare Earths, and a $7.8B Biotech Buyout
As the final hour of trading unfolds, momentum is clustering around breakthrough science, regulatory catalysts, strategic commodities, and headline M&A. Here are the stocks commanding attention into the close and potentially into afterhours.